Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'PECK RW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 20 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Joseph, G; Kelsey, RG; Peck, RW; Niwa, CG
      Response of some scolytids and their predators to ethanol and 4-allylanisole in pine forests of central Oregon

      JOURNAL OF CHEMICAL ECOLOGY
    2. SEABER EJ; PECK RW; SMITH DA; ALLANSON J; HEFTING NR; VANLIER JJ; SOLLIE FAE; WEMER J; JONKMAN JHG
      THE ABSOLUTE BIOAVAILABILITY AND EFFECT OF FOOD ON THE PHARMACOKINETICS OF ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    3. PECK RW; WOOTTON R; WIGGS R; LAYTON G; POSNER J
      EFFECT OF FOOD AND GENDER ON THE PHARMACOKINETICS OF TUCARESOL IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    4. SOULLAWTON JH; WEATHERLEY BC; POSNER J; LAYTON G; PECK RW
      LACK OF INTERACTION BETWEEN VALACICLOVIR, THE L-VALYL ESTER OF ACYCLOVIR, AND DIGOXIN

      British journal of clinical pharmacology
    5. PECK RW; SEABER EJ; DIXON RM; LAYTON GR; WEATHERLEY BC; JACKSON SHD; ROLAN PE; POSNER J
      THE PHARMACODYNAMICS AND PHARMACOKINETICS OF THE 5HT(1B 1D)-AGONIST ZOLMITRIPTAN IN HEALTHY-YOUNG AND ELDERLY MEN AND WOMEN/

      Clinical pharmacology and therapeutics
    6. VERONESE L; GILLOTIN C; MARIONGALLOIS R; WEATHERLEY BC; THEBAULT JJ; GUILLAUME M; PECK RW
      LACK OF INTERACTION BETWEEN ORAL DIHYDROERGOTAMINE AND THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS

      Clinical drug investigation
    7. GILLOTIN C; BAGNIS C; MAMET JP; PECK RW; DERAY G
      NO NEED TO ADJUST THE DOSE OF 311C90 (ZOLMITRIPTAN), A NOVEL ANTIMIGRAINE TREATMENT, IN PATIENTS WITH RENAL-FAILURE NOT REQUIRING DIALYSIS

      International journal of clinical pharmacology and therapeutics
    8. PECK RW; SEABER EJ; DIXON R; GILLOTIN CG; WEATHERLEY BC; LAYTON G; POSNER J
      THE INTERACTION BETWEEN PROPRANOLOL AND THE NOVEL ANTIMIGRAINE AGENT ZOLMITRIPTAN (311C90)

      British journal of clinical pharmacology
    9. SEABER E; ON N; DIXON RM; GIBBENS M; LEAVENS WJ; LIPTROT J; CHITTICK G; POSNER J; ROLAN PE; PECK RW
      THE ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (311C90)

      British journal of clinical pharmacology
    10. DIXON R; GILLOTIN C; GIBBENS M; POSNER J; PECK RW
      THE PHARMACOKINETICS AND EFFECTS ON BLOOD-PRESSURE OF MULTIPLE DOSES OF THE NOVEL ANTIMIGRAINE DRUG ZOLMITRIPTAN (311C90) IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    11. SEABER EJ; RIDOUT G; LAYTON G; POSNER J; PECK RW
      THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (ZOMIG 311C90) HAS NO CLINICALLY SIGNIFICANT INTERACTIONS WITH PARACETAMOL OR METOCLOPRAMIDE

      European Journal of Clinical Pharmacology
    12. PECK RW; EQUIHUAMARTINEZ A; ROSS DW
      SEASONAL FLIGHT PATTERNS OF BARK AND AMBROSIA BEETLES (COLEOPTERA, SCOLYTIDAE) IN NORTHEASTERN OREGON

      The Pan-Pacific entomologist
    13. LEROY F; GODIN M; LEGALLICLER B; FILLASTRE JP; BIDAULT R; POSNER J; PECK RW
      PHARMACOKINETICS OF NETIVUDINE IN HEMODIALYSIS-PATIENTS

      Journal of antimicrobial chemotherapy
    14. FILLASTRE JP; GODIN M; LEGALLICIER B; CHRETIEN P; BIDAULT R; GILLOTIN C; WOOTON R; POSNER J; PECK RW
      PHARMACOKINETICS OF NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS DRUG, IN PATIENTS WITH RENAL IMPAIRMENT

      Journal of antimicrobial chemotherapy
    15. PECK RW; CROME P; WOOD MJ; MCKENDRICK MW; BANNISTER B; MANDAL BK; CROOKS RJ
      MULTIPLE-DOSE NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS AGENT,IN HEALTHY ELDERLY VOLUNTEERS AND PATIENTS WITH SHINGLES

      Journal of antimicrobial chemotherapy
    16. PECK RW; WOOTTON R; LEE DR; JACKSON SHD; POSNER J
      THE BIOAVAILABILITY AND DISPOSITION OF 1-(BETA-D-ARABINOFURANOSYL)-5-(1-PROPYNYL)URACIL (882C87), A POTENT, NEW ANTI-VARICELLA ZOSTER VIRUSAGENT

      British journal of clinical pharmacology
    17. PECK RW; WEATHERLEY BC; WOOTTON R; CROME P; HOLDICH TAH; POSNER J
      PHARMACOKINETICS AND TOLERABILITY OF SINGLE ORAL DOSES OF 882C87, A POTENT, NEW ANTI-VARICELLA-ZOSTER VIRUS AGENT, IN HEALTHY-VOLUNTEERS

      Antimicrobial agents and chemotherapy
    18. PECK RW; WIGGS R; POSNER J
      THE TOLERABILITY, PHARMACOKINETICS AND LACK OF EFFECT ON PLASMA-CHOLESTEROL OF 447C88, AN ACYLCOA-CHOLESTEROL-ACYL-TRANSFERASE (ACAT) INHIBITOR WITH LOW BIOAVAILABILITY, IN HEALTHY-VOLUNTEERS

      European Journal of Clinical Pharmacology
    19. ROLAN PE; MERCER AJ; WEATHERLEY BC; HOLDICH T; MEIRE H; PECK RW; RIDOUT G; POSNER J
      EXAMINATION OF SOME FACTORS RESPONSIBLE FOR A FOOD-INDUCED INCREASE IN ABSORPTION OF ATOVAQUONE

      British journal of clinical pharmacology
    20. WOOD MJ; MCKENDRICK MW; BANNISTER B; MANDAL BK; PECK RW; CROOKS RJ
      PRELIMINARY PHARMACOKINETICS AND SAFETY OF 882C87 IN PATIENTS WITH HERPES-ZOSTER

      Journal of medical virology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 19:55:15